Dr. Ricardo Y. Mabanta, MD

Dr. Mabanta practices at Virtua Medical Group, PA in Marlton, New Jersey.

Dr. Mabanta's NPI, 1730130840, was assigned on May 13, 2006. Dr. Mabanta holds New Jersey license MA059597.

Dr. Mabanta's primary practice is Virtua Medical Group, PA, at 651 State Highway 73 N, Marlton, NJ 08053 in Burlington County. The practice phone is (856) 355-0340.

Dr. Mabanta's primary practice is Virtua Medical Group, PA in Marlton, New Jersey. Dr. Mabanta is also affiliated with Virtua Voorhees Hospital. The medical group on file is Virtua Medical Group. Dmand AI also links Dr. Mabanta to 4 more hospitals, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mabanta practices, 7 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Mabanta's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Mabanta is licensed in New Jersey.

CMS data shows 6,216 Medicare services from Dr. Mabanta across 10 procedure codes in 2024, for 716 Medicare patients. Medicare paid $150,564 for them.

CMS counts 716 Medicare patients who saw Dr. Mabanta in 2024. The largest group is 65 to 74, with 254 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mabanta's median patient age at 62, with 60% women.

In 2024, Dr. Mabanta wrote 1,528 Medicare Part D claims for 416 patients. 89% of them were for generic drugs. CMS names the drug for 1,280 of them, across 31 drugs with 11 or more claims each, at $250,721 in total drug cost. In 2023, CMS named 1,202 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Mabanta for performance year 2024, reported as part of a group. Dr. Mabanta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mabanta as offering telehealth.

CMS Open Payments shows 808 general payments to Dr. Mabanta from 58 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Abbvie Inc. paid the most, $1,380.